Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
genOway

November 2025

genOway Market Share Analysis for November 2025

These scientific posters are presented by both our expert team and clients using our models at conferences around the globe.
Year Founded1999
Employees51 - 200
Annual Revenue$10M - $15M
genoway.com
genOway
genOway (including company regionals)
  • genoway.com
    genoway.com
See more website traffic and engagement information

genOway Revenue up to November 2025 is 10M - 15M

revenue generated by genOway top domains

genOway top domains revenue over 3 years

Revenue for genOway top domains


Total visits to genOway's top domains

Understand genOway market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in genOway's top domains

Analyze genOway engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on genOway's top domains

See how genOway keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by genOway

These are the website technologies, by industry, used by genOway top domains

Advertising (7)

Google Adsense

Google Adsense

Conversion & Analytics (5)

Google Analytics

Google Analytics

Widget (4)

reCAPTCHA

reCAPTCHA

Audio Video Media (3)

YouTube

YouTube

More Technologies

9

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from genOway

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsgenOway SA is developing models and solutions." Through an exclusive worldwide license of Merck's foundational CRISPR integration patents, genOway will develop new models and solutions allowing non-profit and for-profit scientists to use CRISPR/Cas9 technology.
NewsgenOway SA partnered with Merck on Dec 1st '18.In December 2018, genOway entered into an exclusive worldwide license agreement with Merck for the use of its foundational CRISPR integration patents for preclinical applications in the rodent field.
NewsMerck sold assets to genOway SA on Jan 1st '20.- In 2020, GenOway acquired exclusive worldwide rights from Merck for its foundational CRISPR/Cas9 portfolio in the rodent field.

See all genOway signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.